<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80-vaccines-08-00224">
 <label>80.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Xiao</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Cao</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1056/NEJMc2007575</pub-id>
 </element-citation>
</ref>
